The Fund Grade · free · no account needed
What grade does CHCLX get?
Morningstar rates funds on what they returned. We grade them on where their money sits today: how much of the book overlaps with the converged buys of the top specialist stock pickers.
Fundprints Fund Grade · as of 2026-10-01
AB Discovery Growth Fund, Inc. - Class A
#293 of 500 graded active funds · growth · mid segment peer group
The point · specialist footprint
CHCLX puts less of its book behind proven specialists than 85% of graded funds.
● Bottom 20%
Bottom 40%
Middle
Top 40%
Top 20%
That has mattered: over the past 2.7 years, funds with this little specialist backing trailed top-rung funds by about 3.8% per quarter and beat the S&P in only 22% of fund-quarters. If it also charges an active fee, the higher-graded alternatives deserve a look.
10,000+ funds tracked · the graded specialists among them drive every read
3 funds in the same segment carry an A. Members see the names and what they charge. See the alternatives →
The grade scores this fund's specialist share, the slice that overlaps what the top 1% of proven funds are building. We ignore index ballast and names outside our edge on purpose: that slice is small, and it's what decides the outcome.
CHCLX vs the Honor Roll · share card ↗Conviction exposure
3.7%
of the book in specialist-converged names
Late-stage weight
29.7%
of the book in Crowded or Fading names
Active share
94.2%
how far it strays from the index
The best grades have beaten the worst by about +5% a year since we began grading. The gap held in 9 out of 10 months. Measured on filings as they were published, no hindsight.
Inside the book: top names by stage · as of 2026-10-20
We email you the day it crosses 50% crowded, and where you stand every month.
Graded monthly from point-in-time filings. A description of where the money sits, not a recommendation. Evidence, not advice.
The read · what to do with it
CHCLX grades C, ranking 293 of 500, with specialist ownership at just 3.7 percent, meaning few proven stock pickers are backing this fund right now. Nearly 30 percent sits in late-stage positions, and names like FIX and CAVA are actively being exited by specialists. The brighter spots are early-conviction holds in Rocket Lab, Bloom Energy, and Lattice Semiconductor, where the fund is genuinely ahead of the crowd.
→ Watch the combined 10.6 percent weight in fading positions like FIX, CAVA, and FN, as specialist exits often precede price weakness.
→ Three higher-graded funds exist in the same segment, so compare their specialist backing and fees before staying committed to CHCLX.
Support leaving these positions
Read from today's disclosed book. Evidence, not advice.